Injectable Cement Market Report 2024

This Injectable Cement market report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The injectable cement market size has grown strongly in recent years. It will grow from $1.37 billion in 2023 to $1.45 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The historical growth can be attributed to a rise in osteoporosis cases, an increase in bone fractures, a growing demand for joint replacement surgeries, regulatory approvals, and the introduction of new products into the market.

The injectable cement market size is expected to see strong growth in the next few years. It will grow to $1.88 billion in 2028 at a compound annual growth rate (CAGR) of 6.6%. The anticipated growth during the forecast period is driven by an aging population, growing concerns about bone health, the expansion of healthcare infrastructure, increased adoption of outpatient care, and a rise in sports-related injuries. Key trends for this period include improvements in biocompatibility, innovations in antibiotic-loaded cement, advancements in minimally invasive application techniques, development of patient-specific solutions, and smart cement with monitoring capabilities.

The increasing incidence of sports-related injuries is projected to drive the growth of the injectable cement market. Sports-related injuries, which include strains, sprains, fractures, and concussions sustained during athletic activities, often necessitate medical treatment and rehabilitation for recovery. The rise in such injuries is likely due to heightened participation in sports, more rigorous training regimens, and advancements in sports equipment that push physical limits, resulting in higher injury rates among athletes globally. Injectable cement serves as a treatment option for sports-related injuries by stabilizing fractures, supporting bone healing, and improving surgical outcomes through a reliable and minimally invasive method for bone reinforcement. For example, in 2023, the National Safety Council, a US-based nonprofit dedicated to health and safety, reported a 20% increase in sports and recreational injuries in 2021, a 12% rise in 2022, and a 2% uptick in 2023. Consequently, the growing number of sports-related injuries is expected to boost the injectable cement market.

Leading companies in the injectable cement market are concentrating on technological advancements, such as antibiotic-loaded bone cement, to enhance infection control, improve patient outcomes, and provide more effective and targeted treatments during orthopedic surgeries. Antibiotic-loaded bone cement incorporates antibiotics into the cement material to prevent or treat infections at the surgical site, particularly in orthopedic procedures. For instance, in April 2024, Heraeus Medical GmbH, a Germany-based medical technology manufacturer, introduced COPAL G+C, its latest antibiotic-loaded bone cement. This product, certified under the MDR, combines gentamicin and clindamycin, enabling targeted infection management in arthroplasty by addressing up to 90% of pathogens commonly associated with prosthetic joint infections.

In September 2023, Globus Medical Inc., a US-based provider of musculoskeletal solutions including orthopedic cement, merged with NuVasive Inc. for an undisclosed amount. This merger is intended to strengthen Globus Medical’s position in spinal surgery technologies, enhance its ability to deliver innovative, minimally invasive solutions, and stimulate growth in the market. NuVasive Inc., a US-based medical device company, offers spinal treatment solutions, including injectable bone cement.

Major companies operating in the injectable cement market are Johnson & Johnson, 3M Company, Medtronic Plc., Stryker Corporation, B. Braun Melsungen AG, Zimmer Biomet Holdings Inc, Smith & Nephew, Arthrex Inc., Cook Medical LLC, Enovis Corporation, Globus Medical Inc, Wright Medical Group N.V, Medacta International, Orthofix Medical Inc, Alphatec Spine Inc. (ATEC Spine), Exactech Inc., Spine Wave Inc., Tecres SpA, Somatex Medical Technologies, Heraeus Medical GmbH, DJO Global Inc., TEKNIMED, G-21, Kyeron Medical Innovations, Graftys SA.

North America was the largest region in the injectable cement market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the injectable cement market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the injectable cement market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Injectable cement is a specialized type of bone cement used in orthopedic procedures to stabilize fractures, support implants, or fill bone defects. It is designed for injection into a targeted body area, often guided by imaging, which allows for precise placement with minimal invasiveness. Injectable cements are appreciated for providing immediate stabilization, supporting minimally invasive techniques, and enhancing patient outcomes in orthopedic care.

There are three main types of injectable cement, high-viscosity, low-viscosity, and medium-viscosity. High-viscosity cement has a thicker consistency, making it less fluid but offering better stability once hardened, which is ideal for high-stress fractures or complex joint replacements. Applications include periprosthetic fractures, pelvic fractures, and other conditions, with end users such as hospitals, clinics, and additional healthcare facilities.

The injectable cement market research report is one of a series of new reports that provides injectable cement market statistics, including injectable cement industry global market size, regional shares, competitors with an injectable cement market share, detailed injectable cement market segments, market trends and opportunities, and any further data you may need to thrive in the injectable cement industry. This injectable cement market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The injectable cement market consists of sales of antibiotic-loaded bone cements, calcium phosphate cements, customizable injectable cement, and bioactive glass cement. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.